Preliminary data of clinical studies also indicated that GLP-1 infusion may improve cardiac contractile function in chronic heart failure (CHF) patients with and without diabetes, and in MI patients after successful angioplasty [6]. The gene discussed is GCG; the disease is myocardial infarction.